About us
We Fouces on Leveraging Artifical inteligence to Design and modify proteins and small Molecules
Who we are & what we do
Blue Dopamine is a trailblazer in the biotechnology industry, focused on leveraging artificial intelligence to revolutionize the design of proteins, vaccines, and drugs. Our core mission is to harness the power of advanced AI algorithms and molecular modeling to push the boundaries of protein engineering. We provide innovative solutions that enable precise, efficient, and customizable biomolecule design for a range of applications in medicine, environmental sustainability, and beyond. By blending cutting-edge technology with deep biological insights, Blue Dopamine is not just responding to the challenges of today but is actively shaping the future of healthcare and biotechnology.
2019 - Start of the Journey
We embarked on our mission to revolutionize protein and molecule design with AI, initiating research on developing our platform.
2020 - Start Development of Molecule Design Model
Began crafting an AI model focused on accelerating the discovery and design of novel molecules.
2021 - Protein Design Model Development
We initiated the development of an AI-driven protein design model to engineer novel proteins with bespoke functionalities.
2022 -Protein-Drug Interaction Model Development
We started creating a model to predict protein-drug interactions, aiming to enhance the development of safer, more effective drugs.
2023 -Starting Evaluating Our Models
We began evaluating our platform by granting access to some academics, who are assessing its utility in their projects